Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
With the market down by more than 21% in 2022, we're officially in a bear market, and many investors are scrambling to protect themselves. And one solid way to protect your portfolio from falling share prices in the bear market is to load up on stocks that aren't having any trouble outperforming it.
On that note, there are two pharmaceutical businesses that are weathering the decline thanks to their strong financial performance and slew of positive catalysts. Here's why they're likely to continue with their winning streaks -- and why it could be worthwhile to invest $1,000 in each.
AbbVie's (NYSE: ABBV) stock is up 9.9% this year, and with a bunch of recently reported clinical trial results and green lights from regulators, it isn't too surprising why.
Source Fool.com
